RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
Authors
Keywords
-
Journal
PROSTATE
Volume 68, Issue 8, Pages 820-829
Publisher
Wiley
Online
2008-03-07
DOI
10.1002/pros.20744

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.